Sutro Biopharma, Inc. (STRO)
21.39
+0.90
(+4.39%)
USD |
NASDAQ |
Aug 25, 16:00
21.39
0.00 (0.00%)
After-Hours: 19:59
Sutro Biopharma Max Drawdown (5Y) : 98.10% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.10% |
| June 30, 2026 | 98.10% |
| May 31, 2026 | 98.10% |
| April 30, 2026 | 98.10% |
| March 31, 2026 | 98.10% |
| February 28, 2026 | 98.10% |
| January 31, 2026 | 98.10% |
| December 31, 2025 | 98.10% |
| November 30, 2025 | 98.10% |
| October 31, 2025 | 98.10% |
| September 30, 2025 | 98.10% |
| August 31, 2025 | 98.10% |
| July 31, 2025 | 98.10% |
| June 30, 2025 | 98.10% |
| May 31, 2025 | 98.10% |
| April 30, 2025 | 98.10% |
| March 31, 2025 | 97.64% |
| February 28, 2025 | 94.37% |
| January 31, 2025 | 93.75% |
| December 31, 2024 | 93.39% |
| November 30, 2024 | 92.48% |
| October 31, 2024 | 92.48% |
| September 30, 2024 | 92.48% |
| August 31, 2024 | 92.48% |
| July 31, 2024 | 92.48% |
| Date | Value |
|---|---|
| June 30, 2024 | 92.48% |
| May 31, 2024 | 92.48% |
| April 30, 2024 | 92.48% |
| March 31, 2024 | 92.48% |
| February 29, 2024 | 92.48% |
| January 31, 2024 | 92.48% |
| December 31, 2023 | 92.48% |
| November 30, 2023 | 92.48% |
| October 31, 2023 | 90.70% |
| September 30, 2023 | 88.05% |
| August 31, 2023 | 87.62% |
| July 31, 2023 | 87.62% |
| June 30, 2023 | 87.62% |
| May 31, 2023 | 87.62% |
| April 30, 2023 | 87.62% |
| March 31, 2023 | 87.62% |
| February 28, 2023 | 87.62% |
| January 31, 2023 | 87.62% |
| December 31, 2022 | 87.62% |
| November 30, 2022 | 87.62% |
| October 31, 2022 | 87.62% |
| September 30, 2022 | 87.62% |
| August 31, 2022 | 87.62% |
| July 31, 2022 | 87.62% |
| June 30, 2022 | 87.62% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Praxis Precision Medicines, Inc. | 98.67% |
| Upstream Bio, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.22 |
| Beta (5Y) | 1.547 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 86.23% |
| Historical Sharpe Ratio (5Y) | -0.4173 |
| Historical Sortino (5Y) | -0.8354 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.56% |